Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Bayer Inc.

02 1Gowling Lafleur Henderson LLP

03 9Gowling WLG (Canada) LLP

04 3Gowlings

05 2Ridout & Maybee LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
CPhI Korea
Not Confirmed
arrow
CPhI Korea
Not Confirmed

Interferon Beta-1A

Brand Name : BETASERON

Patent Number : 1340861

Filing Date : 1983-10-12

Strength per Unit : 0.3mg per vial (250 ug / mL when reconstituted)

Dosage Form : Lyophilized powder with accompanying diluent

Human Or VET : Human

Route of Administration : Subcutanous injection

Patent Expiration Date : 2016-12-28

Date Granted : 1999-12-28

blank

02

arrow
CPhI Korea
Not Confirmed
arrow
CPhI Korea
Not Confirmed

Interferon Beta-1A

Brand Name : BETASERON

Patent Number : 1339707

Filing Date : 1986-08-20

Strength per Unit : 0.3mg per vial (250 ug / mL when reconstituted)

Dosage Form : Lyophilized powder with accompanying diluent

Human Or VET : Human

Route of Administration : Subcutanous injection

Patent Expiration Date : 2015-03-10

Date Granted : 1998-03-10

blank

03

arrow
CPhI Korea
Not Confirmed
arrow
CPhI Korea
Not Confirmed

Interferon Beta-1A

Brand Name : FERONA

Patent Number : 1339707

Filing Date : 1986-08-20

Strength per Unit : 0.3 mg / vial (250 ?g / ml)

Dosage Form : Lyophilized powder with accompanying diluent

Human Or VET : Human

Route of Administration : Subcutaneous Injection

Patent Expiration Date : 2015-03-10

Date Granted : 1998-03-10

blank

04

arrow
CPhI Korea
Not Confirmed
arrow
CPhI Korea
Not Confirmed

Interferon Beta-1A

Brand Name : FERONA

Patent Number : 1340861

Filing Date : 1983-10-12

Strength per Unit : 0.3 mg / vial (250 ?g / ml)

Dosage Form : Lyophilized powder with accompanying diluent

Human Or VET : Human

Route of Administration : Subcutaneous Injection

Patent Expiration Date : 2016-12-28

Date Granted : 1999-12-28

blank

05

arrow
CPhI Korea
Not Confirmed
arrow
CPhI Korea
Not Confirmed

Interferon Beta-1A

Brand Name : AVONEX

Patent Number : 1341604

Filing Date : 1981-04-04

Strength per Unit : 30 mcg / 0.5mL

Dosage Form : solution

Human Or VET : Human

Route of Administration : Intramuscular

Patent Expiration Date : 2027-05-04

Date Granted : 2010-05-04

blank

06

arrow
CPhI Korea
Not Confirmed
arrow
CPhI Korea
Not Confirmed

Interferon Beta-1A

Brand Name : AVONEX

Patent Number : 1341604

Filing Date : 1981-04-04

Strength per Unit : 30 mcg / mL

Dosage Form : Lyophilized powder for resonstitution

Human Or VET : Human

Route of Administration : Intramuscular injection

Patent Expiration Date : 2027-05-04

Date Granted : 2010-05-04

blank

07

arrow
CPhI Korea
Not Confirmed

Gowlings

Canada
arrow
CPhI Korea
Not Confirmed

Interferon Beta-1A

Brand Name : EXTAVIA

Patent Number : 1340861

Filing Date : 1983-10-12

Strength per Unit : 0.3 mg / vial

Dosage Form : Powder for Solution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2016-12-28

Date Granted : 1999-12-28

blank

08

arrow
CPhI Korea
Not Confirmed

Gowlings

Canada
arrow
CPhI Korea
Not Confirmed

Interferon Beta-1A

Brand Name : EXTAVIA

Patent Number : 1339707

Filing Date : 1986-08-20

Strength per Unit : 0.3 mg / vial

Dosage Form : Powder for Solution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2015-03-10

Date Granted : 1998-03-10

blank

09

arrow
CPhI Korea
Not Confirmed

Gowlings

Canada
arrow
CPhI Korea
Not Confirmed

Interferon Beta-1A

Brand Name : EXTAVIA

Patent Number : 2428144

Filing Date : 2001-11-07

Strength per Unit : 0.3 mg / vial

Dosage Form : Powder for Solution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2021-11-07

Date Granted : 2012-01-10

blank

10

arrow
CPhI Korea
Not Confirmed
arrow
CPhI Korea
Not Confirmed

Interferon Beta-1A

Brand Name : AVONEX

Patent Number : 2275890

Filing Date : 1997-12-23

Strength per Unit : 30 mcg / 0.5mL

Dosage Form : solution

Human Or VET : Human

Route of Administration : Intramuscular

Patent Expiration Date : 2017-12-23

Date Granted : 2011-11-01

blank